| Mary Caitlyn Purvis, DPT | |
|
960 Commonwealth Blvd, Tupelo, MS 38804-3880 | |
| (662) 260-3789 | |
| (662) 290-3790 |
| Full Name | Mary Caitlyn Purvis |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 960 Commonwealth Blvd, Tupelo, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174139265 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT6968 (Mississippi) | Primary |
| Provider Name | Dpti Elite Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1386010718 PECOS PAC ID: 0547579401 Enrollment ID: O20151016001144 |
News Archive
People diagnosed with a deadly form of cancer will no longer face the prospect of having a needle inserted into their eye thanks to a new blood test developed by Edith Cowan University researchers.
The second night of the 2020 Democratic National Convention featured a 17-person keynote speech, past presidents, a roll call vote that doubled as a virtual tour of the United States and an emphasis on health care and national security issues.
Chronic nerve pain results from pathological changes within a nerve that appear to be self-sustaining and thus the pain continues for a long time.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 8 days ago
| Provider Name | Drayer Physical Therapy Mississippi Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1952732448 PECOS PAC ID: 3274834858 Enrollment ID: O20160314001040 |
News Archive
People diagnosed with a deadly form of cancer will no longer face the prospect of having a needle inserted into their eye thanks to a new blood test developed by Edith Cowan University researchers.
The second night of the 2020 Democratic National Convention featured a 17-person keynote speech, past presidents, a roll call vote that doubled as a virtual tour of the United States and an emphasis on health care and national security issues.
Chronic nerve pain results from pathological changes within a nerve that appear to be self-sustaining and thus the pain continues for a long time.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Caitlyn Purvis, DPT 7065 Airways Blvd Ste 110, Southaven, MS 38671-5874 Ph: () - | Mary Caitlyn Purvis, DPT 960 Commonwealth Blvd, Tupelo, MS 38804-3880 Ph: (662) 260-3789 |
News Archive
People diagnosed with a deadly form of cancer will no longer face the prospect of having a needle inserted into their eye thanks to a new blood test developed by Edith Cowan University researchers.
The second night of the 2020 Democratic National Convention featured a 17-person keynote speech, past presidents, a roll call vote that doubled as a virtual tour of the United States and an emphasis on health care and national security issues.
Chronic nerve pain results from pathological changes within a nerve that appear to be self-sustaining and thus the pain continues for a long time.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 8 days ago
Tupelo Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1743 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-680-5216 | |
Molly Bryan Davis, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 154 Merritt Dr, Tupelo, MS 38801 Phone: 785-826-6134 | |
John Everett, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 830 S Gloster St, Tupelo, MS 38801 Phone: 662-377-4058 | |
Jennifer L Rodabough, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2089 Southridge Dr, Tupelo, MS 38801 Phone: 662-407-0801 Fax: 662-407-0807 | |
Mr. Mark Chapin Bresee, MPT, OCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 Air Park Rd, Tupelo, MS 38801 Phone: 662-842-2100 Fax: 662-842-2105 | |
Mr. Joseph John Elmer, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1743 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-0602 Fax: 662-680-5217 | |
Sara Westmoreland Smith, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 Briar Ridge Rd, Tupelo, MS 38804 Phone: 716-662-4955 |